Viruses operate covertly these days, hiding in the background instead of attracting attention. Luckily, there are tools to stop them.

According to Liu, his preferred option is faricimab, a fairly new agent that was FDA-approved for wet AMD in 2022. The drug is the first bispecific agent approved to treat AMD, he said, which means it ...